| Unique ID issued by UMIN | UMIN000062958 |
|---|---|
| Receipt number | R000072082 |
| Scientific Title | Combined exercise and nutritional intervention in patients undergoing maintenance hemodialysis with cachexia: A pilot study |
| Date of disclosure of the study information | 2026/09/21 |
| Last modified on | 2026/09/17 13:01:17 |
Combined exercise and nutritional intervention in patients undergoing maintenance hemodialysis with cachexia: A pilot study
Exercise and nutrition intervention in hemodialysis patients
Combined exercise and nutritional intervention in patients undergoing maintenance hemodialysis with cachexia: A pilot study
Exercise and nutrition intervention in hemodialysis patients
| Japan |
End-stage kidney disease on maintenance hemodialysis with cachexia
| Nephrology | Rehabilitation medicine |
Others
NO
To exploratively evaluate the effectiveness of a combined exercise and nutritional intervention for improving cachexia-related symptoms in patients with end-stage kidney disease undergoing maintenance hemodialysis.
Safety,Efficacy
Change in handgrip strength from baseline to 3 months after initiation of the intervention
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
| Medicine | Maneuver |
Participants will receive a 3-month nutritional intervention using an oral nutritional supplement (ENEVO) to achieve a protein intake of 1.2 g/kg/day. In addition, aerobic exercise using an adjustable-load cycle ergometer will be performed during outpatient hemodialysis for 30 minutes per session, three times per week, for 3 months. Exercise intensity will be adjusted to approximately 13 on the Borg Rating of Perceived Exertion Scale.
| 18 | years-old | <= |
| Not applicable |
Male and Female
1. Patients aged 18 years or older at the time of enrollment.
2. Patients with end-stage kidney disease undergoing outpatient maintenance hemodialysis who have cachexia.
3. Patients who have received sufficient explanation about the study and provided written informed consent.
1. Patients with physical or cognitive impairments that may interfere with the conduct of the study.
2. Patients with malignancies or medical conditions requiring active treatment.
3. Patients receiving steroid therapy.
4. Patients in poor general condition with an expected prognosis limited to several months.
5. Patients considered unsuitable for participation in the study by the attending physician.
12
| 1st name | Hideyuki |
| Middle name | |
| Last name | Oritsu |
Yokohama City University Hospital
Department of Rehabilitation
236-0004
3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan
045-787-2800
oritsu@yokohama-cu.ac.jp
| 1st name | Masatsugu |
| Middle name | |
| Last name | Okamura |
Yokohama City University
Department of Rehabilitation Medicine, School of Medicine
236-0004
3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan
045-787-2713
okamura@yokohama-cu.ac.jp
Yokohama City University
Japan Society for the Promotion of Science (JSPS)
Other
Yokohama City University Ethics Committee
3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan
045-370-7627
rinri@yokohama-cu.ac.jp
NO
| 2026 | Year | 09 | Month | 21 | Day |
Unpublished
Preinitiation
| 2026 | Year | 04 | Month | 03 | Day |
| 2026 | Year | 10 | Month | 01 | Day |
| 2027 | Year | 03 | Month | 31 | Day |
| 2026 | Year | 09 | Month | 17 | Day |
| 2026 | Year | 09 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072082